Breakdown |
---|
Income Statement |
Total Revenue |
Gross Profit |
EBITDA |
Net Income |
Balance Sheet |
Total Assets |
Cash, Cash Equivalents and Short-Term Investments |
Total Debt |
Total Liabilities |
Stockholders Equity |
Cash Flow |
Free Cash Flow |
Operating Cash Flow |
Investing Cash Flow |
Financing Cash Flow |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $4.75B | 482.28 | 0.97% | ― | 14.52% | ― | |
73 Outperform | $12.04B | 23.14 | 10.30% | 0.81% | 28.87% | 57.72% | |
72 Outperform | $5.96B | 104.27 | 8.56% | ― | 27.32% | ― | |
69 Neutral | ¥230.42B | 14.66 | 7.50% | 2.60% | 9.31% | 5.75% | |
68 Neutral | $21.51B | 948.21 | 0.38% | ― | 17.24% | ― | |
59 Neutral | $4.27B | ― | -33.09% | ― | 13.85% | 3.47% | |
50 Neutral | $3.33B | ― | -4.16% | ― | 17.70% | 61.98% |